On September 8, 2023, Tandem Diabetes Care, Inc. was sued for violations of the federal securities laws in the United States District Court for the Southern District of California on behalf of investors who purchased or otherwise acquired Tandem securities between August 3, 2022 and November 2, 2022 inclusive (the “Class Period”).
We use cookies to improve your overall web experience. By using our website, you consent to the use of cookies in accordance with our Privacy Policy.